P&G Target INCREASED and 4 Must-Notice Stock Analyses

Novadaq (:NVDQ) reported higher than expected revenue, causing JMP Securities to raise its target on the stock, due to upcoming potential catalysts. The firm keeps an Outperform rating on the stock.

Procter & Gamble Co. (NYSE:PG) price target was increased to $71 from $67 by Bank of America Merrill Lynch.

Don’t Miss: Wall Street Brief: Knight Capital Gets BAILED OUT, Six Big IPOs ON DECK.

YM BioSciences, Inc. (AMEX:YMI): After Incyte (NASDAQ:INCY) reported high initial levels of patient discontinuations in a study of Jakafi for myelofibrosis, YM Biosciences shares, which has a similar drug, fell on Friday, according to JMP Securities. The firm thinks that YM Biosciences’ drug could be better suited for patients with anemia. The firm keeps and Outperform rating and a $5 target on the stock.

Procter & Gamble Co. (NYSE:PG) target was raised by BMO Capital following the company’s report of higher than expected Q4 core EPS. The firm mentions that the company’s U.S. market share in a number of categories is improving as the company reduces head count ahead of schedule. The firm reiterates an Outperform rating on the stock.

SM Energy Company (NYSE:SM) price target was lowered by Oppenheimer after the company reported much lower adjusted EPS for Q2 than expected and lowered its outlook for production growth. The firm keeps an Outperform rating, due to valuation.

Don’t Miss: The Week Ahead on Wall Street: Eyes on ECB, Disney and Retailers Deliver Earnings.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.